Related Experiment Video
Updated: Mar 22, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Molecular and Genetic Mechanisms Involved in the Pathogenesis of Cardiorenal Cross Talk
Grazia Maria Virzì1, Anna Clementi, Alessandra Brocca
1Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza, Italy.
Insights
Cardiorenal syndrome involves heart and kidney dysfunction. This review explores novel epigenetic and genetic factors contributing to cardiorenal crosstalk and disease.
Area of Science:
- Cardiology
- Nephrology
- Genetics
Background:
- Cardiorenal syndrome (CRS) describes the co-occurrence of cardiac and renal dysfunction.
- Established mechanisms include inflammation, oxidative stress, apoptosis, and immune dysregulation.
- The intricate crosstalk between the heart and kidneys is not fully understood.
Purpose of the Study:
- To review emerging mechanisms in cardiorenal crosstalk.
- Focus on epigenetics, prenatal programming, noncoding RNAs, and extracellular vesicles.
- Elucidate their potential roles in heart and kidney diseases.
Main Methods:
- Literature review of recent research.
- Analysis of studies investigating novel molecular pathways.
- Synthesis of findings on cardiorenal interactions.
Main Results:
- Epigenetic modifications, prenatal programming, small noncoding RNAs, and extracellular vesicles are implicated in CRS pathogenesis.
- These factors offer new perspectives on the complex heart-kidney axis.
- Understanding these mechanisms could reveal therapeutic targets.
Conclusions:
- Emerging mechanisms like epigenetics and noncoding RNAs significantly contribute to cardiorenal crosstalk.
- Further research into these pathways is crucial for advancing CRS understanding and treatment.
- These novel factors represent a paradigm shift in studying heart and kidney disease interactions.
Abstract:
The term 'cardiorenal syndrome' (CRS) encloses a scenario of clinical interactions in which cardiac and renal dysfunctions coexist. The cross talk between the heart and the kidney is clearly evidenced but not fully understood. Indeed, different factors have been shown to be involved in the pathogenesis of CRS, such as systemic inflammation, oxidative stress, apoptosis and immune dysregulation. Recently, considerable attention has been paid to the role of new alternative mechanisms which may be implicated in the pathogenesis of cardiorenal cross talk. In this review, we will focus on epigenetics, prenatal programming, small noncoding RNAs and extracellular vesicles, aiming to elucidate their possible role in heart and kidney diseases.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Hypertension II: Pathophysiology
Heart Failure Drugs: Diuretics
Hypertension and Regulation of Blood Pressure

